Filing Details
- Accession Number:
- 0001519749-21-000011
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-09-21 18:18:42
- Reporting Period:
- 2021-09-17
- Accepted Time:
- 2021-09-21 18:18:42
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 899923 | Myriad Genetics Inc | MYGN | In Vitro & In Vivo Diagnostic Substances (2835) | 870494517 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1519749 | B. Jayne Hart | 320 Wakara Way Salt Lake City UT 84108 | Chief People Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-09-17 | 73,225 | $26.49 | 153,287 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-09-17 | 64,480 | $33.72 | 88,807 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2021-09-17 | 3,775 | $26.49 | 92,582 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-09-17 | 2,966 | $33.72 | 89,616 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Incentive Stock Option (right to buy) | Disposition | 2021-09-17 | 3,775 | $0.00 | 3,775 | $26.49 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2021-09-17 | 73,225 | $0.00 | 73,225 | $26.49 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2021-09-17 | No | 4 | M | Direct | |
| 0 | 2021-09-17 | No | 4 | M | Direct |
Footnotes
- Represents the net exercise of outstanding stock options. The reporting person received 8,745 shares of common stock on net exercise of options to purchase 73,225 shares of common stock. The company withheld 64,480 shares of common stock for payment of the exercise price and tax withholdings, using the closing stock price on September 17, 2021 of $33.72.
- Represents the net exercise of outstanding stock options. The reporting person received 809 shares of common stock on net exercise of options to purchase 3,775 shares of common stock. The company withheld 2,966 shares of common stock for payment of the exercise price and tax withholdings, using the closing stock price on September 17, 2021 of $33.72.
- The shares subject to this option are fully vested and exercisable.
Billionaire Hedge Funds
